Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Canopy Growth Corp T.WEED

Alternate Symbol(s):  CGC | T.WEED.DB

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.


TSX:WEED - Post by User

Post by sollmgon Jun 19, 2024 9:43pm
187 Views
Post# 36097137

New Coverage

New Coverage

 

 GLOBE says new coverage rates Canopy "sector perform"

 

2024-06-19 07:59 ET - In the News

 

The Globe and Mail reports in its Wednesday, June 19, edition that ATB Capital Markets analyst Frederico Gomes has started coverage on Canopy Growth with a "sector perform" recommendation and $10 share target. The Globe's David Leeder writes in the Eye On Equities column that analysts on average target the shares at $9.13. Mr. Gomes says in a sector "deprived of trading liquidity and institutional engagement," Canopy Growth "delivers a differentiated proposition." Mr. Gomes notes that Canopy is the only company offering direct exposure to cannabis markets in Canada, the United States and Europe, along with a Nasdaq listing. He believes Canopy's valuation "already prices in reasonable growth expectations." Mr. Gomes says in a note: "A comprehensive transformation of Canopy's core business is driving margins in the right direction and reducing cash use, materially derisking the investment case for Canopy. Management has divested assets and transitioned to an asset-light model in Canada, resulting in a cost structure more commensurate with its addressable market and a keener focus on profitability. ... Over the long-term, we think Canopy will re-gain share in Canada as the market rationalizes.

<< Previous
Bullboard Posts
Next >>